Latest Period
Q2 2026
Security Snapshot
Alaunos Therapeutics, Inc. - Common stock (TCRT) Institutional Ownership
CUSIP: 98973P309
13F Institutional Holders and Ownership History from Q2 2024 to Q2 2026
Institutions Reporting
29
Shares (Excl. Options)
90,383
Price
$2.26
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common stock
- Symbol
- TCRT on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 90,383
- Total 13F value
- $204,421
- Portfolio coverage rank
- 0%
- Share change
- -35,726
- Value change
- -$101,229
- Number of holders
- 29
- Shares outstanding
- 2,198,384
- SEC-reported price per share
- $2.26
- Insider filing price
- $2.26
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- TCRT - Alaunos Therapeutics, Inc. - Common stock is tracked under CUSIP 98973P309.
- 29 institutions reported positions in Q2 2026.
- 2 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 28 to 29 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $359,538 to $204,421.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 29 institutions filings for Q2 2026.
Security key
98973P309
Latest holder period
Q2 2026
13F holders
29
13D/G owners
2
CIK / CUSIP context first
Open Q2 2026 holders
TCRT full holder history
Alaunos Therapeutics, Inc. SEC filings
Alaunos Therapeutics, Inc. company facts
Alaunos Therapeutics, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 98973P309:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
2
Security
TCRT
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Postma Robert W | 9% | $615,372 | 199,796 | Postma Robert W | 24 Jun 2025 | |||
| Price Adrian | 8.6% | 0% | $491,559 | 189,061 | 0% | Price Adrian | 24 Feb 2026 |
As of 30 Jun 2026, 29 institutional investors reported holding 90,383 shares of Alaunos Therapeutics, Inc. - Common stock (TCRT). This represents 4.1% of the company’s total 2,198,384 outstanding shares.
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
9
Latest
Q2 2026
Rows shown
1-9 of 9
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 90,383 | $204,421 | -$101,229 | $2.26 | 29 |
| 2026 Q1 | 125,752 | $359,538 | +$50,029 | $2.86 | 28 |
| 2025 Q4 | 108,542 | $349,893 | +$139,293 | $3.23 | 26 |
| 2025 Q3 | 65,224 | $158,311 | -$15,260 | $2.41 | 24 |
| 2025 Q2 | 70,942 | $344,079 | +$2,573 | $4.85 | 25 |
| 2025 Q1 | 70,134 | $102,359 | -$2,277 | $1.47 | 25 |
| 2024 Q4 | 72,015 | $136,970 | -$361,475 | $1.90 | 28 |
| 2024 Q3 | 192,061 | $622,752 | +$549,975 | $3.22 | 28 |
| 2024 Q2 | 37 | $25 | +$25 | $0.68 | 3 |